68Ga-DPA scan for lung cancer diagnosis
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new imaging agent called 68Ga-DPA to see if it can help find and measure lung cancer tumors. It is for people who are suspected or confirmed to have lung cancer and need a biopsy or surgery soon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have been told you might have or have been diagnosed with lung cancer.
- You must have a tumor that can be measured on a scan, such as a CT or MRI.
- You need to have had a biopsy or surgery for lung cancer in the last 2 months.
- You must be expected to live for more than 3 months.
- You must be able to lie flat on your back for 30 minutes without moving.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a specific PET/CT scan (a whole-body imaging test) to help evaluate cancer that is confirmed or suspected. If you are eligible, you may receive this scan soon after a recent FDG PET/CT to compare or improve how cancers are identified.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial uses a new radioactive tracer that attaches to a protein found on many solid tumors, allowing doctors to see tumors on a PET scan. It may help improve how tumors are detected and monitored.
This trial looks at a specific PET/CT scan using a tracer called 68Ga to create detailed images of prostate cancer. It may help doctors see where cancer is in the body more clearly.
This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.
This trial uses a special PET/CT scan to find breast cancer cells that have a certain marker (CD73). It may help doctors see the cancer more clearly before you start other treatments.
Hear when a new Lung Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.